ID   Tu-132
AC   CVCL_4909
SY   TU 132; Tu 132; Tu132; TU132; T132
DR   BTO; BTO_0004879
DR   Wikidata; Q54973306
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=19465936;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=14655754; DOI=10.1111/j.1750-3639.2003.tb00479.x; PMCID=PMC8095903;
RA   Bahr O., Rieger J., Duffner F., Meyermann R., Weller M., Wick W.;
RT   "P-glycoprotein and multidrug resistance-associated protein mediate
RT   specific patterns of multidrug resistance in malignant glioma cell
RT   lines, but not in primary glioma cells.";
RL   Brain Pathol. 13:482-494(2003).
//
RX   PubMed=17595512; DOI=10.1159/000104150;
RA   Rieger J., Frank B., Weller M., Wick W.;
RT   "Mechanisms of resistance of human glioma cells to Apo2
RT   ligand/TNF-related apoptosis-inducing ligand.";
RL   Cell. Physiol. Biochem. 20:23-34(2007).
//
RX   PubMed=19465936; DOI=10.1038/onc.2009.104;
RA   Gramatzki D., Pantazis G., Schittenhelm J., Tabatabai G., Kohle C.,
RA   Wick W., Schwarz M., Weller M., Tritschler I.;
RT   "Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad
RT   pathway in human glioblastoma cells.";
RL   Oncogene 28:2593-2605(2009).
//